{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T02:39:39Z","timestamp":1711507179347},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T00:00:00Z","timestamp":1467072000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00105-016-3828-9","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T10:00:51Z","timestamp":1467194451000},"page":"627-634","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Neues zur Therapie des chronischen Pruritus"],"prefix":"10.1007","volume":"67","author":[{"given":"C.","family":"Zeidler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pfleiderer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"St\u00e4nder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,28]]},"reference":[{"issue":"1","key":"3828_CR1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/exd.12587","volume":"24","author":"I Arai","year":"2015","unstructured":"Arai I, Tsuji M, Miyagawa K et al (2015) Repeated administration of IL-31 upregulates IL-31 receptor A (IL-31RA) in dorsal root ganglia and causes severe itch-associated scratching behaviour in mice. Exp Dermatol 24(1):75\u201378","journal-title":"Exp. Dermatol."},{"issue":"3","key":"3828_CR2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0190-9622(86)70201-6","volume":"15","author":"JE Bernstein","year":"1986","unstructured":"Bernstein JE, Parish LC, Rapaport M et\u00a0al (1986) Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J\u00a0Am Acad Dermatol 15(3):504\u2013507","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"3828_CR3","first-page":"665","volume":"164","author":"N Booken","year":"2011","unstructured":"Booken N, Heck M, Nicolay JP et al (2011) Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T\u2011cell lymphoma. Br J Dermatol 164(3):665\u2013667","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"3828_CR4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaad.2014.10.034","volume":"72","author":"E Brenaut","year":"2015","unstructured":"Brenaut E, Marcorelles P, Genestet S et al (2015) Pruritus: an underrecognized symptom of small-fiber neuropathies. J Am Acad Dermatol 72(2):328\u2013332","journal-title":"J. Am. Acad. Dermatol."},{"issue":"12","key":"3828_CR5","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s00105-004-0802-8","volume":"55","author":"A Brune","year":"2004","unstructured":"Brune A, Metze D, Luger TA et al (2004) Antipruritische Therapie mit dem oralen Opiatrezeptorantagonisten Naltrexon. Offene, nicht placebokontrollierte Anwendung bei 133 Patienten (Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients). Hautarzt 55(12):1130\u20131136","journal-title":"Hautarzt"},{"issue":"1","key":"3828_CR6","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1152\/ajpregu.00446.2006","volume":"292","author":"MJ Caterina","year":"2007","unstructured":"Caterina MJ (2007) Transient receptor potential ion channels as participants in thermosensation and thermoregulation. Am J Physiol Regul Integr Comp Physiol 292(1):R64\u2013R76","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"12","key":"3828_CR7","first-page":"1440","volume":"13","author":"B Chia","year":"2014","unstructured":"Chia B, Yong K, Tey HL (2014) Metastatic hepatocellular carcinoma with paraneoplastic itch: effective treatment with naltrexone. J\u00a0Drugs Dermatol 13(12):1440","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"3828_CR8","first-page":"297","volume":"150","author":"A Cristaudo","year":"2015","unstructured":"Cristaudo A, Francesconi L, Ambrifi M et\u00a0al (2015) Efficacy of an emollient dermoprotective cream in the treatment of elderly skin affected by xerosis. G Ital Dermatol Venereol 150(3):297\u2013302","journal-title":"G Ital Dermatol Venereol"},{"issue":"2","key":"3828_CR9","first-page":"172","volume":"15","author":"ZD Draelos","year":"2016","unstructured":"Draelos ZD, Gold S, Linda F, Murrell DF et\u00a0al (2016) Post hoc analyses of the effect of crisaborole topical ointment, 2\u202f% on atopic dermatitis: associated pruritus from phase 1 and 2 clinical studies. J\u00a0Drugs Dermatol 15(2):172\u2013176","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"3828_CR10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK (1994) Dermatology Life Quality Index (DLQI) \u2013 a simple practical measure for routine clinical use. Clin Exp Dermatol 19(3):210\u2013216","journal-title":"Clin. Exp. Dermatol."},{"issue":"5","key":"3828_CR11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijmedinf.2011.12.008","volume":"81","author":"F Fritz","year":"2012","unstructured":"Fritz F, Balhorn S, Riek M et al (2012) Qualitative and quantitative evaluation of EHR-integrated mobile patient questionnaires regarding usability and cost-efficiency. Int J Med Inform 81(5):303\u2013313","journal-title":"Int J Med Inform"},{"issue":"2","key":"3828_CR12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1529-8019.2010.01314.x","volume":"23","author":"G Gencoglan","year":"2010","unstructured":"Gencoglan G, Inanir I, Gunduz K (2010) Therapeutic hotline: Treatment of prurigo nodularis and lichen simplex chronicus with gabapentin. Dermatol Ther 23(2):194\u2013198","journal-title":"Dermatol Ther"},{"issue":"3","key":"3828_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2310\/6620.2011.10110","volume":"22","author":"AR Ghorbani","year":"2011","unstructured":"Ghorbani AR, Feily A, Khalili A et al (2011) Lack of efficacy of topical calcineurin inhibitor pimecrolimus 1\u202f% on pruritus of severely uremic patients: a randomized double-blind study in 60 patients. Dermatitis 22(3):167\u2013168","journal-title":"Dermatitis"},{"issue":"10","key":"3828_CR14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2217\/imt.15.69","volume":"7","author":"JD Hamilton","year":"2015","unstructured":"Hamilton JD, Ungar B, Guttman-Yassky E (2015) Drug evaluation review: dupilumab in atopic dermatitis. Immunotherapy 7(10):1043\u20131058","journal-title":"Immunotherapy"},{"issue":"7","key":"3828_CR15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1468-3083.2010.03865.x","volume":"25","author":"S Hammes","year":"2011","unstructured":"Hammes S, Hermann J, Roos S et al (2011) UVB 308-nm excimer light and bath PUVA: combination therapy is very effective in the treatment of prurigo nodularis. J Eur Acad Dermatol Venereol 25(7):799\u2013803","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"3828_CR16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10227-005-0144-x","volume":"9","author":"S Ingber","year":"2005","unstructured":"Ingber S, Cohen PD (2005) Successful treatment of refractory aquagenic pruritus with naltrexone. J\u00a0Cutan Med Surg 9(5):215\u2013216","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"3828_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/0975-7406.171736","volume":"8","author":"TM Khan","year":"2016","unstructured":"Khan TM, Aziz A, Suleiman AK (2016) Effectiveness of posthemodialysis administration of pregabalin (75\u202fmg) in treatment resistance uremia pruritus. J\u00a0Pharm Bioallied Sci 8(1):74\u201376","journal-title":"J Pharm Bioallied Sci"},{"issue":"5","key":"3828_CR18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1684\/ejd.2013.2100","volume":"23","author":"M Ko","year":"2013","unstructured":"Ko M, Chiu H, Jee S et\u00a0al (2013) Postprandial blood glucose is associated with generalized pruritus in patients with type 2 diabetes. Eur J Dermatol 23(5):688\u2013693","journal-title":"Eur J Dermatol"},{"issue":"6","key":"3828_CR19","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2014.08.004","volume":"71","author":"M Ko","year":"2014","unstructured":"Ko M, Peng Y, Chen H et al (2014) Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis. J Am Acad Dermatol 71(6):1151\u20131159","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"3828_CR20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/ijms17030425","volume":"17","author":"MJ Lavery","year":"2016","unstructured":"Lavery MJ, Stull C, Kinney MO et\u00a0al (2016) Nocturnal Pruritus: the battle for a peaceful night\u2019s sleep. Int J Mol Sci 17(3):425","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3828_CR21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/bmjspcare-2014-000790","volume":"6","author":"JJ Lee","year":"2016","unstructured":"Lee JJ, Girouard SD, Carlberg VM et\u00a0al (2016) Effective use of mirtazapine for refractory pruritus associated with carcinoma en cuirasse. BMJ Support Palliat Care 6(1):119\u2013121","journal-title":"BMJ Support Palliat Care"},{"issue":"2 Pt 1","key":"3828_CR22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0190-9622(94)70022-2","volume":"30","author":"T Lotti","year":"1994","unstructured":"Lotti T, Teofoli P, Tsampau D (1994) Treatment of aquagenic pruritus with topical capsaicin cream. J\u00a0Am Acad Dermatol 30(2 Pt 1):232\u2013235","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"3828_CR23","first-page":"137","volume":"4","author":"A Makhlough","year":"2010","unstructured":"Makhlough A, Ala S, Haj-Heydari Z et al (2010) Topical capsaicin therapy for uremic pruritus in patients on hemodialysis. Iran J Kidney Dis 4(2):137\u2013140","journal-title":"Iran J Kidney Dis"},{"issue":"3","key":"3828_CR24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaad.2015.05.025","volume":"73","author":"A Maley","year":"2015","unstructured":"Maley A, Swerlick RA (2015) Azathioprine treatment of intractable pruritus: a retrospective review. J\u00a0Am Acad Dermatol 73(3):439\u2013443","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"3828_CR25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2340\/00015555-1572","volume":"93","author":"U Matterne","year":"2013","unstructured":"Matterne U, Apfelbacher CJ, Vogelgsang L et al (2013) Incidence and determinants of chronic pruritus: a population-based cohort study. Acta Derm Venereol 93(5):532\u2013537","journal-title":"Acta Derm. Venereol."},{"issue":"1","key":"3828_CR26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jcpt.12005","volume":"38","author":"M Mazza","year":"2013","unstructured":"Mazza M, Guerriero G, Marano G et\u00a0al (2013) Treatment of prurigo nodularis with pregabalin. J\u00a0Clin Pharm Ther 38(1):16\u201318","journal-title":"J Clin Pharm Ther"},{"issue":"7","key":"3828_CR27","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3109\/10428194.2014.983098","volume":"56","author":"RA Mesa","year":"2015","unstructured":"Mesa RA, Scherber RM, Geyer HL (2015) Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitors. Leuk Lymphoma 56(7):1989\u20131999","journal-title":"Leuk. Lymphoma"},{"issue":"7","key":"3828_CR28","first-page":"864","volume":"95","author":"L Misery","year":"2015","unstructured":"Misery L, Erfan N, Castela E et al (2015) Successful treatment of refractory neuropathic pruritus with capsaicin 8\u202f% patch: a bicentric retrospective study with long-term follow-up. Acta Derm Venereol 95(7):864\u2013865","journal-title":"Acta Derm. Venereol."},{"issue":"4","key":"3828_CR29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2332\/allergolint.10-OA-0182","volume":"59","author":"H Murota","year":"2010","unstructured":"Murota H, Kitaba S, Tani M et al (2010) Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases. Allergol Int 59(4):345\u2013354","journal-title":"Allergol Int"},{"key":"3828_CR30","doi-asserted-by":"crossref","unstructured":"Narbutt J, Olejniczak I, Sobolewska-Sztychny D et al ( 2013) Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients. Arch Dermatol Res 305:191\u2013195.","DOI":"10.1007\/s00403-012-1293-6"},{"key":"3828_CR31","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2417","author":"LA Nattkemper","year":"2016","unstructured":"Nattkemper LA, Martinez-Escala M, Gelman AB et al (2016) Cutaneous T\u2011cell lymphoma and pruritus: the expression of IL-31 and its receptors in the skin. Acta Derm Venereol doi:10.2340\/00015555-2417","journal-title":"Acta Derm. Venereol."},{"issue":"2","key":"3828_CR32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/bjd.14207","volume":"174","author":"O Nemoto","year":"2016","unstructured":"Nemoto O, Furue M, Nakagawa H et al (2016) The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study. Br J Dermatol 174(2):296\u2013304","journal-title":"Br. J. Dermatol."},{"key":"3828_CR33","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2016.1161161","author":"E Nofal","year":"2016","unstructured":"Nofal E, Farag F, Nofal A et al (2016) Gabapentin: A promising therapy for uremic pruritus in hemodialysis patients: a randomized-controlled trial and review of literature. J Dermatolog Treat:1\u20135. doi:10.3109\/09546634.2016.1161161","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"3828_CR34","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaad.2009.08.052","volume":"63","author":"NQ Phan","year":"2010","unstructured":"Phan NQ, Bernhard JD, Luger TA et al (2010) Antipruritic treatment with systemic \u03bc\u2011opioid receptor antagonists: a review. J Am Acad Dermatol 63(4):680\u2013688","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"3828_CR35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11882-014-0423-y","volume":"14","author":"A Rabenhorst","year":"2014","unstructured":"Rabenhorst A, Hartmann K (2014) Interleukin-31: a novel diagnostic marker of allergic diseases. Curr Allergy Asthma Rep 14(4):423","journal-title":"Curr Allergy Asthma Rep"},{"issue":"10","key":"3828_CR36","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1470-2045(12)70373-X","volume":"13","author":"D Santini","year":"2012","unstructured":"Santini D, Vincenzi B, Guida FM et\u00a0al (2012) Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study. Lancet Oncol 13(10):1020\u20131024","journal-title":"Lancet Oncol."},{"issue":"6","key":"3828_CR37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/09546630903386606","volume":"21","author":"R Saraceno","year":"2010","unstructured":"Saraceno R, Chiricozzi A, Nistic\u00f2 SP et\u00a0al (2010) An occlusive dressing containing betamethasone valerate 0.1\u202f% for the treatment of prurigo nodularis. J\u00a0Dermatolog Treat 21(6):363\u2013366","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"3828_CR38","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00105-009-1730-4","volume":"60","author":"S Schulz","year":"2009","unstructured":"Schulz S, Metz M, Siepmann D et al (2009) Antipruritische Wirksamkeit einer hoch dosierten Antihistaminikatherapie. Ergebnisse einer retrospektiv analysierten Fallserie (Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series). Hautarzt 60(7):564\u2013568","journal-title":"Hautarzt"},{"issue":"4","key":"3828_CR39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000355671","volume":"227","author":"D Siepmann","year":"2013","unstructured":"Siepmann D, Lotts T, Blome C et al (2013) Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: results of a randomized, hydrocortisone-controlled, double-blind phase II trial. Dermatology (Basel) 227(4):353\u2013360","journal-title":"Dermatology (Basel)"},{"issue":"4","key":"3828_CR40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2340\/00015555-2360","volume":"96","author":"JM Sobell","year":"2016","unstructured":"Sobell JM, Foley P, Toth D et\u00a0al (2016) Effects of apremilast on pruritus and skin discomfort\/pain correlate with improvements in quality of life in patients with moderate to severe plaque psoriasis. Acta Derm Venereol 96(4):514\u2013520","journal-title":"Acta Derm. Venereol."},{"issue":"4","key":"3828_CR41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/ced.12365","volume":"39","author":"P Spring","year":"2014","unstructured":"Spring P, Gschwind I, Gilliet M (2014) Prurigo nodularis: retrospective study of 13 cases managed with methotrexate. Clin Exp Dermatol 39(4):468\u2013473","journal-title":"Clin. Exp. Dermatol."},{"issue":"1","key":"3828_CR42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2340\/00015555-0553","volume":"89","author":"S Stander","year":"2009","unstructured":"Stander S, Bockenholt B, Schurmeyer-Horst F et al (2009) Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study. Acta Derm Venereol 89(1):45\u201351","journal-title":"Acta Derm. Venereol."},{"issue":"3","key":"3828_CR43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1067\/mjd.2001.110059","volume":"44","author":"S St\u00e4nder","year":"2001","unstructured":"St\u00e4nder S, Luger T, Metze D (2001) Treatment of prurigo nodularis with topical capsaicin. J\u00a0Am Acad Dermatol 44(3):471\u2013478","journal-title":"J. Am. Acad. Dermatol."},{"key":"3828_CR44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-3-662-44605-8_14","volume":"226","author":"S St\u00e4nder","year":"2015","unstructured":"St\u00e4nder S, Luger TA (2015) NK-1 antagonists and itch. Handb Exp Pharmacol 226:237\u2013255","journal-title":"Handb Exp Pharmacol"},{"issue":"3","key":"3828_CR45","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2340\/00015555-1949","volume":"95","author":"S St\u00e4nder","year":"2015","unstructured":"St\u00e4nder S, Pogatzki-Zahn E, Stumpf A et al (2015) Facing the challenges of chronic pruritus: a report from a multi-disciplinary medical itch centre in Germany. Acta Derm Venereol 95(3):266\u2013271","journal-title":"Acta Derm. Venereol."},{"issue":"6","key":"3828_CR46","doi-asserted-by":"crossref","first-page":"e10968","DOI":"10.1371\/journal.pone.0010968","volume":"5","author":"S St\u00e4nder","year":"2010","unstructured":"St\u00e4nder S, Siepmann D, Herrgott I et\u00a0al (2010) Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS ONE 5(6):e10968","journal-title":"PLoS ONE"},{"issue":"6","key":"3828_CR47","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/bjd.12267","volume":"168","author":"S St\u00e4nder","year":"2013","unstructured":"St\u00e4nder S, Stumpf A, Osada N et\u00a0al (2013) Gender differences in chronic pruritus: women present different morbidity, more scratch lesions and higher burden. Br J Dermatol 168(6):1273\u20131280","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"3828_CR48","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/bjd.13492","volume":"172","author":"A Stumpf","year":"2015","unstructured":"Stumpf A, Stander S, Warlich B et\u00a0al (2015) Relations between the characteristics and psychological comorbidities of chronic pruritus differ between men and women: women are more anxious than men. Br J Dermatol 172(5):1323\u20131328","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"3828_CR49","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/dth.12028","volume":"26","author":"A Stumpf","year":"2013","unstructured":"Stumpf A, St\u00e4nder S (2013) Neuropathic itch: diagnosis and management. Dermatol Ther 26(2):104\u2013109","journal-title":"Dermatol Ther"},{"issue":"2","key":"3828_CR50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2011.05.024","volume":"66","author":"E Suys","year":"2012","unstructured":"Suys E (2012) Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani. J\u00a0Am Acad Dermatol 66(2):327\u2013328","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"3828_CR51","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2133.1994.tb08529.x","volume":"131","author":"RM Szeimies","year":"1994","unstructured":"Szeimies RM, Stolz W, Wlotzke U et al (1994) Successful treatment of hydroxyethyl starch-induced pruritus with topical capsaicin. Br J Dermatol 131(3):380\u2013382","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"3828_CR52","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00520-010-0895-9","volume":"18","author":"B Vincenzi","year":"2010","unstructured":"Vincenzi B, Fratto ME, Santini D et\u00a0al (2010) Aprepitant against pruritus in patients with solid tumours. Support Care Cancer 18(9):1229\u20131230","journal-title":"Support Care Cancer"},{"issue":"3","key":"3828_CR53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000437206","volume":"231","author":"B Warlich","year":"2015","unstructured":"Warlich B, Fritz F, Osada N et al (2015) Health-related quality of life in chronic pruritus: an analysis related to disease etiology, clinical skin conditions and itch intensity. Dermatology (Basel) 231(3):253\u2013259","journal-title":"Dermatology (Basel)"},{"issue":"5","key":"3828_CR54","first-page":"589","volume":"13","author":"TM Weber","year":"2014","unstructured":"Weber TM, Babcock MJ, Herndon JH et al (2014) Steroid-free emollient formulations reduce symptoms of eczema and improve quality of life. J Drugs Dermatol 13(5):589\u2013595","journal-title":"J Drugs Dermatol"},{"issue":"12","key":"3828_CR55","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1681\/ASN.2005020152","volume":"16","author":"B Wikstr\u00f6m","year":"2005","unstructured":"Wikstr\u00f6m B, Gellert R, Ladefoged SD et al (2005) Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol 16(12):3742\u20133747","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"3828_CR56","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1346-8138.2010.00830.x","volume":"37","author":"S Yilmaz","year":"2010","unstructured":"Yilmaz S, Ceyhan AM, Baysal Akkaya V (2010) Brachioradial pruritus successfully treated with gabapentin. J\u00a0Dermatol 37(7):662\u2013665","journal-title":"J. Dermatol."},{"key":"3828_CR57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/dth.12309","volume":"29","author":"M Zanardelli","year":"2015","unstructured":"Zanardelli M, Kovacevic M, McCoy J et\u00a0al (2015) Management of chronic pruritus with a UV filtering topical cream. Dermatol Ther 29:101","journal-title":"Dermatol Ther"},{"issue":"6","key":"3828_CR58","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/bjd.13501","volume":"172","author":"C Zeidler","year":"2015","unstructured":"Zeidler C, L\u00fcling H, Dieckh\u00f6fer A et\u00a0al (2015) Capsaicin 8\u202f% cutaneous patch: a promising treatment for brachioradial pruritus? Br J Dermatol 172(6):1669\u20131671","journal-title":"Br. J. Dermatol."},{"key":"3828_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13165","author":"C Zeidler","year":"2015","unstructured":"Zeidler C, Metze D, St\u00e4nder S (2015) Successful treatment of lichen amyloidosis using capsaicin 8\u202f% patch. J\u00a0Eur Acad Dermatol Venereol doi:10.1111\/jdv.13165","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"3828_CR60","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00105-014-2757-8","volume":"65","author":"C Zeidler","year":"2014","unstructured":"Zeidler C, St\u00e4nder S (2014) Therapie der Prurigo nodularis (Therapy of prurigo nodularis). Hautarzt 65(8):709\u2013713","journal-title":"Hautarzt"},{"issue":"1","key":"3828_CR61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2011.04185.x","volume":"26","author":"T Zuberbier","year":"2012","unstructured":"Zuberbier T (2012) Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses. J Eur Acad Dermatol Venereol 26(1):9\u201318","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3828-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-016-3828-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3828-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T02:57:47Z","timestamp":1600829867000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-016-3828-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,28]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["3828"],"URL":"https:\/\/doi.org\/10.1007\/s00105-016-3828-9","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,28]]}}}